Clinical Trial Update: VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating sildenafil for improving walking distance in patients with peripheral artery disease and intermittent claudication. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Rennes University Hospital | Conditions: Peripheral Artery Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING